Our results confirm that imrecoxib can inhibit EMT of paraquat-induced A549 cells and alleviate paraquat-induced pulmonary fibrosis through the NF-κB/snail signal pathway. The gene discussed is NFKB1; the disease is pulmonary fibrosis.